List view / Grid view

Heidi Olzscha

 

article

Academia Big Pharma collaboration in drug development

Clearly what is needed is a synergistic collaboration bringing together…

5 May 2014 | By

Clearly what is needed is a synergistic collaboration bringing together the respective competence and expertise of academia and industry. All the major pharmaceutical companies have recognised this need and have introduced a range of different models for association with academia and small biotech or biopharma companies. Attempted solutions range from…

article

Oncology biomarkers in clinical practice – a new horizon

The ability to individualise a patient’s care has become a…

4 May 2014 | By , ,

The ability to individualise a patient’s care has become a particularly pressing issue in the field of cancer therapeutics as there is a growing recognition that both the global incidence of cancer is steadily rising and the associated costs in terms of treatment and lost productivity are ever increasing. Advances…